Jim Cramer Said Stay Away From This Drone Stock a Week Before Its Biggest Earnings Beat in Years

Jim Cramer publicly warned investors away from AeroVironment just one week before the drone and laser maker dropped a report that forced everyone to rethink the competition story he called too dangerous to touch.

Published September 10, 2026, 9:18am ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A yellow and black delivery drone with four propellers, carrying a white and orange package, flies in the foreground. In the background, a sprawling modern city with numerous high-rise buildings lines a wide river with several bridges, under a bright, partly cloudy sky. The entire image is overlaid with transparent blue and teal financial bar charts and upward-trending line graphs.
A delivery drone soars over an urban landscape, reflecting the technological advancements and market dynamics driving growth in the drone sector, as highlighted by recent earnings reports. © Shutterstock

On September 2, Jim Cramer told Mad Money viewers he was saying “not yet, not now” on AeroVironment (NASDAQ:AVAV | AVAV Price Prediction) because competition in its corner of defense was too strong. Seven days later, the drone and laser maker posted the biggest earnings beat it has produced in years.

I have been following defense-tech names for a while, and this is the kind of setup that punishes conviction on both sides. Shares walked into the report down 5% on the day and are down 39% year to date. Then the numbers hit.

Numbers That Blew Past the Bar

Fiscal Q1 2027 adjusted EPS came in at $0.59 versus the $0.2479 consensus, a 138% surprise. Revenue of $480.49 million topped the $456.09 million estimate and grew 5.7% year over year. Bookings landed at roughly $700 million for a 1.4x book-to-bill, and funded backlog hit a record $1.50 billion, up 37% year over year.

AVAV earnings explorer

CEO Wahid Nawabi said: “AV’s fiscal year 2027 is off to a strong start, with record first-quarter revenue and funded backlog and landmark strategic wins.”

The LOCUST Bet Gets Real

Directed energy was the standout. AeroVironment landed a $464 million LOCUST award for the Army’s Enduring High Energy Laser program, which Nawabi called “the first ever production contract for direct energy systems in U.S. military history.” He said LOCUST fires at “under $10 per shot” and predicted the product line could become a “well over a half a billion dollar plus a year franchise” within roughly a year.

Compare that to Cramer’s competition worry. Nawabi said on the call that on the P550 reconnaissance program, “We’re essentially getting well over 80% of the dollars of those awards so far, maybe close to 90% of the awards.” The $117 million P550 win is part of what he expects to become a $1 billion program over the next few years.

Where the Caution Still Fits

Cramer’s skepticism is not without evidence. GAAP net income remained a loss of $5.07 million. The Space, Cyber and Directed Energy segment fell 21% year over year to $134.52 million. Free cash flow was negative $36 million, and management reaffirmed rather than raised guidance of $2.125 billion to $2.225 billion in revenue with non-GAAP EPS of $3.02 to $3.34. Roughly 70% of non-GAAP EPS is back-half weighted, and Nawabi flagged uncertainty over “how fast can Congress approve the next fiscal year’s budget?”

Still, last quarter’s smaller 25% beat produced a 19% one-day jump. In pre-market Thursday, shares were quoted at $147.42. If you believed Cramer on September 2, the question now is whether the competition thesis survives a record backlog and the Army’s first production laser contract. If you did not, the record backlog says the turn may already be underway.

AVAV price target

Contact [email protected] for any questions or corrections.

Jeremy Phillips

I've been writing about stocks and personal finance for 20+ years. I believe all great companies are tech companies in the long run, and I invest accordingly.

All articles →